The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Open accessAbstract
Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathogenic forms of tau spread toxicity between cells through a prion-like mechanism involving seeded conformational change (Colin et al. 2020, Frost et al. 2009).”
From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Frost et al. 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence indicate tau propagates pathology among neurons.”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
From Network analysis identifies strain-dependent response to tau and tau seeding-associated genes (2023) · cites this paper as Frost et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Tau assemblies enter cells to trigger intracellular aggregation (Frost et al., 2009; Holmes et al., 2014)”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
In the citing paper
“The aggregation of tau impairs the axons, leading to neurodegeneration [23].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [23]
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [267]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Flagged first, then by citations
Research works printed but not linked: 2
- Delacourte, 2005, Polish Acad. Sci., 43, 244
- DePace, 2002, Nat. Struct. Biol., 9, 389
Cited by
Sorted by citations
Items 501–600 of 1,001
Amelioration of Tau pathology and memory deficits by targeting 5-HT7 receptor
Labus, J., Röhrs, K., Ackmann, J., Varbanov, H., Müller, F. E., Jia, S., Jahreis, K., Vollbrecht, A.-L., Butzlaff, M., Schill, Y., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101900 · Cited by 50
NAKAI, T., Yamada, K., & Mizoguchi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115549 · Cited by 53
Suttkus, A., Holzer, M., Morawski, M., & Arendt, T. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.040 · Cited by 50
Prions: Beyond a Single Protein
Das, A. S., & Zou, W. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-15 · Cited by 52
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 58
How the shapes of seeds can influence pathology
Melki, R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.011 · Cited by 50
Nonaka, T., Masuda‐Suzukake, M., Hosokawa, M., Shimozawa, A., Hirai, S., Okado, H., & Hasegawa, M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy174 · Cited by 53
Kaur, P., Khera, A., Alajangi, H. K., Sharma, A., Jaiswal, P. K., Singh, G., & Barnwal, R. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03164-z · Cited by 55
Calcium phosphatase calcineurin influences tau metabolism
Karch, C. M. M., Jeng, A. T., & Goate, A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.003 · Cited by 51
Inhibitory Act of Selenoprotein P on Cu+/Cu2+-Induced Tau Aggregation and Neurotoxicity
Du, X., Zheng, Y., Wang, Z., Chen, Y., Zhou, R., Song, G.-L., Ni, J., & Liu, Q. (2014) · Inorganic Chemistry · doi:10.1021/ic501788v · Cited by 49
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
d’Abramo, C., Acker, C. M., Jimenez, H. T., & Davies, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135774 · Cited by 49
Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Papy-García, D., Christophe, M., Huynh, M. B., Siñeriz, F., Sissoëff, L., Sepulveda-Diaz, J. E., & Raisman‐Vozari, R. (2011) · Current Protein and Peptide Science · doi:10.2174/138920311795860188 · Cited by 53
Transmission of Neurodegenerative Disorders Through Blood Transfusion
Edgren, G., Hjalgrim, H., Rostgaard, K., Lambert, P. C., Wikman, A. T., Norda, R., Titlestad, K.-E., Erikstrup, C., Ullum, H., Melbye, M., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2421 · Cited by 49
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 50
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 48
Prions: generation and spread versus neurotoxicity.
Halliday, M., Radford, H. E., & Mallucci, G. R. (2014) · Figshare · doi:10.17863/cam.14500 · Cited by 48
TDP-43 PrionsPreprint
Nonaka, T., & Hasegawa, M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024463 · Cited by 50
Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells
Wang, L., Jiang, Q., Chu, J., Lin, L., Li, X.-G., Chai, G.-S., Wang, Q., Wang, J.-Z., & Tian, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076057 · Cited by 47
Sun, Y.-R., Lv, Q.-K., Liu, J., Wang, F., & Liu, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106791 · Cited by 48
Prion-like propagation of cytosolic protein aggregates
Nussbaum-Krammer, C. I., Schätzl, H. M., & Vorberg, I. M. (2009) · Prion · doi:10.4161/pri.3.4.10013 · Cited by 48
Brief update on different roles of tau in neurodegeneration
Ittner, A., Ke, Y. D., van Eersel, J., Gladbach, A., Götz, J., & Ittner, L. M. (2011) · IUBMB Life · doi:10.1002/iub.467 · Cited by 49
Gaikwad, S., Puangmalai, N., Sonawane, M., Montalbano, M., Price, R., Iyer, M. S., Ray, A., Moreno, S., & Kayed, R. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5958 · Cited by 46
Vassileff, N., Vella, L. J., Rajapaksha, H., Shambrook, M., Kenari, A. N., McLean, C., Hill, A. F., & Cheng, L. (2020) · Cells · doi:10.3390/cells9071709 · Cited by 48
Tau internalization: A complex step in tau propagation
Zhao, J., Wu, H., & Tang, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101272 · Cited by 47
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 47
Frost, B., & Dubnau, J. (2024) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-082823-020615 · Cited by 45
Self-citationWalker, L., & Attems, J. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230154 · Cited by 48
Kerchner, G., Bernstein, J. D., Fenesy, M. C., Deutsch, G., Saranathan, M., Zeineh, M. M., & Rutt, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1915-13.2013 · Cited by 44
Giustiniani, J., Guillemeau, K., Dounane, O., Sardin, E., Huvent, I., Schmitt, A., Hamdane, M., Buée, L., Landrieu, I., Lippens, G. M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-268243 · Cited by 48
Cell-to-cell propagation of infectious cytosolic protein aggregates
Hofmann, J. P., Denner, P., Nussbaum-Krammer, C. I., Kuhn, P., Suhre, M. H., Scheibel, T., Lichtenthaler, S. F., Schätzl, H. M., Bano, D., & Vorberg, I. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217321110 · Cited by 46
Katsinelos, T., Tuck, B. J., Mukadam, A. S., & McEwan, W. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01139 · Cited by 46
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 46
Derreumaux, P., Man, V. H., Wang, J., & Nguyen, P. H. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c00574 · Cited by 45
Disruption of nuclear envelope integrity as a possible initiating event in tauopathies
Prissette, M., Fury, W., Koss, M., Racioppi, C., Fedorova, D., Dragileva, E., Clarke, G., Pohl, T., Dugan, J., Ahrens, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111249 · Cited by 41
Prion-Like Protein Aggregates and Type 2 DiabetesPreprint
Mukherjee, A., & Soto, C. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024315 · Cited by 46
The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43
RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds
Zwierzchowski-Zarate, A. N., Mendoza‐Oliva, A., Kashmer, O. M., Collazo-Lopez, J. E., White, C. L., & Diamond, M. I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102132 · Cited by 48
Self-citationEltom, K., Mothes, T., Libard, S., Ingelsson, M., & Erlandsson, A. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01745-8 · Cited by 46
TDP ‐43 in amyotrophic lateral sclerosis – is it a prion disease?
Ludolph, A. C., & Brettschneider, J. (2015) · European Journal of Neurology · doi:10.1111/ene.12706 · Cited by 45
Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice
Lü, D., Giles, K., Li, Z., Rao, S., Dolghih, E., Gever, J. R., Geva, M., Elepano, M., Oehler, A., Bryant, C., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.205799 · Cited by 44
Recent developments with tau-based drug discovery
Iqbal, K., Liu, F., & Gong, C. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1445084 · Cited by 46
Recent advancements toward therapeutic vaccines against Alzheimer’s disease
Herline, K., Drummond, E., & Wısnıewskı, T. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1500905 · Cited by 46
Xia, Y., Sorrentino, Z. A., Kim, J. D., Strang, K. H., Riffe, C. J., & Giasson, B. I. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010178 · Cited by 48
Goodwin, M. S., Sinyavskaya, O., Burg, F., O’Neal, V., Ceballos‐Diaz, C., Cruz, P. E., Lewis, J. M., Giasson, B. I., Davies, P., Golde, T. E., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.007 · Cited by 46
Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.703876 · Cited by 47
Gibbons, G. S., Kim, S., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H. W., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00404-5 · Cited by 45
Local structural preferences in shaping tau amyloid polymorphism
Louros, N. N., Wilkinson, M., Tsaka, G., Ramakers, M., Morelli, C., Garcia, T., Gallardo, R. U., D’Haeyer, S., Goossens, V., Audenaert, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45429-2 · Cited by 42
Is tau ready for admission to the prion club?
Hall, G. F., & Patuto, B. A. (2012) · Prion · doi:10.4161/pri.19912 · Cited by 43
Initiation and propagation of neurodegeneration
Haass, C. (2010) · Nature Medicine · doi:10.1038/nm.2223 · Cited by 45
Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
Meyer, V., Dinkel, P. D., Luo, Y., Yu, X., Wei, G., Zheng, J., Eaton, G. R., Ma, B., Nussinov, R., Eaton, S. S., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308473 · Cited by 42
Interneurons in the human olfactory system in Alzheimer's disease
Saiz‐Sánchez, D., Flores‐Cuadrado, A., Úbeda‐Bañón, I., de la Rosa‐Prieto, C., & Martı́nez-Marcos, A. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.009 · Cited by 44
Differences in Aβ brain networks in Alzheimer's disease and healthy controls
Duan, H., Jiang, J., Xu, J. L., Zhou, H., Huang, Z., Yu, Z., & Yan, Z. (2016) · Brain Research · doi:10.1016/j.brainres.2016.11.019 · Cited by 42
Forrest, S. L., Lee, S., Nassir, N., Martínez-Valbuena, I., Sackmann, V., Li, J., Ahmed, A., Tartaglia, M. C., Ittner, L. M., Lang, A. E., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02604-x · Cited by 44
Feinstein, H. E., Benbow, S. J., LaPointe, N. E., Patel, N., Ramachandran, S., Do, T. D., Gaylord, M. R., Huskey, N. E., Dressler, N., Korff, M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13604 · Cited by 45
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41
Stefano, M. E. D., & Herrero, M. T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.08.002 · Cited by 42
Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment
Su, L., Hayes, L., Soteriades, S., Williams, G. B., Brain, S., Firbank, M., Longoni, G., Arnold, R. J., Rowe, J. B., & O'Brien, J. T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170344 · Cited by 41
Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis
Klein, O., & Sagi‐Eisenberg, R. (2019) · Journal of Immunology Research · doi:10.1155/2019/9542656 · Cited by 44
Annadurai, N., Sanctis, J. B. D., Hajdúch, M., & Das, V. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113756 · Cited by 41
Chaperoning shape-shifting tau in disease
Ryder, B. D., Wydorski, P. M., Hou, Z., & Joachimiak, Ł. A. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.12.009 · Cited by 44
Seed-competent tau monomer initiates pathology in a tauopathy mouse model
Mirbaha, H., Chen, D., Mullapudi, V., Terpack, S. J., White, C. L., Joachimiak, Ł. A., & Diamond, M. I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102163 · Cited by 39
Self-citationFRMD4A–cytohesin signaling modulates the cellular release of tau
Yan, X., Nykänen, N.-P., Brunello, C. A., Haapasalo, A., Hiltunen, M. O., Uronen, R., & Huttunen, H. J. (2016) · Journal of Cell Science · doi:10.1242/jcs.180745 · Cited by 43
Selenica, M.-L. B., Davtyan, H., Housley, S. B., Blair, L. J., Gillies, A., Nordhues, B. A., Zhang, B., Liu, J., Gestwicki, J. E., Lee, D. C., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0152-0 · Cited by 40
Congdon, E. E., Jiang, Y., & Sigurdsson, E. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.12.002 · Cited by 38
Type-I Interferons in Alzheimer's Disease and Other Tauopathies
Sanford, S., & McEwan, W. A. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.949340 · Cited by 42
Distinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains
Karikari, T. K., Nagel, D. A., Grainger, A. I., Clarke-Bland, C., Crowe, J. A., Hill, E. J., & Moffat, K. G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00296 · Cited by 41
Nassor, F., Jarray, R., Biard, D. S. F., Maïza, A., Papy-García, D., Pavoni, S., Deslys, J., & Yates, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00014 · Cited by 39
Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34005-1 · Cited by 43
Spilman, P. R., Corset, V., Gorostiza, O., Poksay, K. S., Galvan, V., Zhang, J., Rao, R., Peters-Libeu, C., Vincelette, J., McGeehan, A., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151046 · Cited by 39
Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
La‐Rocque, S. D., Moretto, E., Butnaru, I., & Schiavo, G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 46
Super-resolution imaging unveils the self-replication of tau aggregates upon seeding
Dimou, E., Katsinelos, T., Meisl, G., Tuck, B. J., Keeling, S., Smith, A. E., Hidari, E., Lam, J. Y. L., Burke, M., Lövestam, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112725 · Cited by 43
Rüb, U., Stratmann, K., Heinsen, H., Turco, D. D., Ghebremedhin, E., Seidel, K., den Dunnen, W. F. A., & Korf, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150639 · Cited by 38
Chua, S. W., Cornejo, A., van Eersel, J., Stevens, C. H., Vaca, I., Cueto, M., Kassiou, M., Gladbach, A., Macmillan, A., Lewis, L., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00433 · Cited by 38
Animal Models for Alzheimer’s Disease and Frontotemporal Dementia: A Perspective
Götz, J., & Götz, N. N. (2009) · ASN NEURO · doi:10.1042/an20090042 · Cited by 38
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39
Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Penke, B., Szűcs, M., & Bogár, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065383 · Cited by 39
Lung endothelium, tau, and amyloids in health and disease
Balczon, R., Lin, M. T., Voth, S. B., Nelson, A. R., Schupp, J. C., Wagener, B. M., Pittet, J., & Stevens, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00006.2023 · Cited by 40
Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
Lambracht‐Washington, D., & Rosenberg, R. N. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s31428 · Cited by 39
Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
Kaufman, S. K., & Diamond, M. I. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0196-3 · Cited by 40
Self-citationPseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy
Morrow, K. A., Ochoa, C. D., Balczon, R., Zhou, C., Cauthen, L., ALEXEYEV, M. F., Schmalzer, K. M., Frank, D. W., & Stevens, T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00103.2015 · Cited by 37
Application of yeast to studying amyloid and prion diseases
Chernoff, Y. O., Grizel, A. V., Rubel, A. A., Zelinsky, A. А., Chandramowlishwaran, P., & Chernova, T. A. (2020) · Advances in genetics · doi:10.1016/bs.adgen.2020.01.002 · Cited by 41
Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
Shin, S. J., Park, Y. H., Jeon, S. G., Kim, S., Nam, Y., Oh, S., Lee, Y. Y., & Moon, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7829842 · Cited by 38
Amro, Z., Yool, A. J., & Collins‐Praino, L. E. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100242 · Cited by 39
The expanding realm of prion phenomena in neurodegenerative disease
Frost, B. E., & Diamond, M. I. (2009) · Prion · doi:10.4161/pri.3.2.8754 · Cited by 36
Self-citationPrion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential TherapyPreprint
Sibilla, C., & Bertolotti, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a024141 · Cited by 37
Clinical update of Jakob–Creutzfeldt disease
Kim, M., & Geschwind, M. D. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000197 · Cited by 36
Convergent Replication of Mouse Synthetic Prion Strains
Ghaemmaghami, S., Colby, D. W., Nguyen, H.-O. B., Hayashi, S., Oehler, A., DeArmond, S. J., & Prusiner, S. B. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.038 · Cited by 36
Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
Almansoub, H. A. M. M., Tang, H. R., Wu, Y., Wang, D., Mahaman, Y. A. R., Wei, N., Almansob, Y. A. M., He, W., & Liu, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180868 · Cited by 39
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
Kang, Y. J., Diep, Y. N., Tran, M., & Cho, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249591 · Cited by 36
Di, J., Siddique, I. A., Li, Z., Malki, G. J., Hornung, S., Dutta, S., Hurst, I., Ishaaya, E., Wang, A., Tu, S., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00743-x · Cited by 38
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 41
Promising Targets for the Treatment of Neurodegenerative Diseases
Haeberlein, S. B., & Harris, T. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.195 · Cited by 35
Sources of Extracellular Tau and its Signaling
Ávila, J., Simón, D., Díaz-Hernández, M., Pintor, J. J., & Hernández, F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131832 · Cited by 36
Pathological Alterations of Tau in Alzheimer’s Disease and 3xTg-AD Mouse Brains
Li, L., Jiang, Y., Hu, W. H., Tung, Y. C., Dai, C., Chu, D., Gong, C., Iqbal, K., & Liu, F. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1507-4 · Cited by 36
Glennon, E. B. C., Lau, D. H. W., Gabriele, R. M. C., Taylor, M. F., Troakes, C., Opie-Martin, S., Elliott, C., Killick, R., Hanger, D. P., Perez‐Nievas, B. G., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa011 · Cited by 36
In vivo network models identify sex differences in the spread of tau pathology across the brain
Shokouhi, S., Taylor, W. D., Albert, K., Kang, H., Newhouse, P. A., & Initiative, T. A. D. N. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12016 · Cited by 35
Role of the endolysosomal pathway and exosome release in tau propagation
Yan, M., & Zheng, T. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104988 · Cited by 36
Tauons and Prions: Infamous Cousins?
Novák, P., Prčina, M., & Kontseková, E. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110194 · Cited by 36
Strittmatter, W. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68241 · Cited by 35
Metadata
- Authors
- Frost, B., Jacks, R. L., & Diamond, M. I.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Diamond, Marc I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 284
- Issue
- 19
- Pages
- 12845-12852
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2676015
- OpenAlex
- W1989208474
- Cited by
- 1,252
- References
- 32
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 76 · 2023: 78 · 2022: 72 · 2021: 96 · 2020: 97 · 2019: 70 · 2018: 67 · 2017: 76 · 2016: 67 · 2015: 83 · 2014: 78 · 2013: 89 · 2012: 81
- FWCI
- 43.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (R01NS050284, R01 NS50284-03)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tauopathy, prion-like propagation, fluid-phase endocytosis, Alzheimer's disease, frontotemporal dementia
- MeSH terms
- Animals, Animals, Newborn, Cell Line, Dextrans, Extracellular Space, Flow Cytometry, Fluorescent Antibody Technique, Humans, Kidney, Luminescent Proteins, Neurons, Stem Cells, Blotting, Western, tau Proteins, Protein Folding, Microscopy, Atomic Force, Coculture Techniques, Intracellular Space, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
